Comprehensive umbrella review of meta-analysis on genetic polymorphisms (SNPs) and their links to hypertension
摘要
Hypertension is a multifaceted disorder with both genetic and environmental contributions. Key Single nucleotide polymorphisms (SNPs) have been linked to critical pathways controlling blood pressure, vascular tone, renal sodium reabsorption, and oxidative stress. This umbrella review summarizes evidence on 21 focal SNPs from ACE, ACE2, AGT, ADD1, ADRB1, ANP, ApoE, CYP11B2, CYP4F2, ENOS, GNB3, LIPC, LEPR, MTHFR, RNLS, STK39, TNF-α, and VDR determining the weight of association, credibility, and clinical significance.
MethodsThis study included 21 meta-analyses, a cumulative total of 392,314 participants were represented. SNPs were organized into six biological pathways: Renin–Angiotensin–Aldosterone System (RAAS), vascular tone, metabolism, oxidative stress, methylation, inflammation. Credibility evaluations included GRADE, Venice Criteria, AMSTAR-2, and NOS with Composite Score which ranked SNP’s based on association and reliability strength. The best predictive SNPs were determined using a Random Forest model.
ResultsPolymorphisms in ACE (I/D), ApoE (ε4), TNF-α (G308A), eNOS (rs1799983), and MTHFR (C677T) showed strong associations (OR > 2.0). Moderate associations included AGT (M235T), LEPR (Gln223Arg), STK39 (rs3754777), and CYP11B2 (C344T). The Random Forest model identified the top predictive SNPs as TNF-α (G308A), ApoE (ε4), and ACE (I/D).
ConclusionIn this umbrella review, the major genetic factors impacting hypertension is outlined with the help of meta-analysis, credibility analysis, and machine learning. SNPs with higher Composite Scores demonstrated stronger potential for clinical application and translational value, which enhances personalized medicine and individual healthcare. More work is required to more effectively prevent and treat hypertension by studying gene-environment interactions.